Stuart Portbury, PhD
Senior Principal Scientist, Biomarkers
Stuart Portbury, PhD joined Acumen as Senior Principal Scientist, Biomarkers in May 2024. He is a highly qualified neurodegenerative disease, biomarker and translational neuroscience portfolio contributor, with a strong emphasis in Alzheimer’s disease pre-clinical and clinical research. Prior to joining Acumen, Stuart was the Senior Scientific Program Manager for ALZpath, supporting the development of a blood-based biomarker test (pTau217) for the early diagnosis of Alzheimer’s disease. Stuart earned his Neuroscience PhD at The University of Melbourne, Australia.